There is a growing demand for portfolios that are better aligned to their beneficiaries’ values and beliefs. A pension fund for nurses may not want exposure to tobacco while a religious foundation might be concerned about the optics of profiting from online betting businesses.
Beyond these value-driven concerns, there is a growing segment of long-term investors that view activities like shale energy production or pesticides as being simply too risky in light of rapidly changing regulations and accompanying lawsuits.
Sustainalytics’ Controversial Product Involvement research enable investors to create investment universes that are aligned to these clients’ mandate and their long-term investment strategy.
Access research on all publicly-listed companies with involvement in the most widely used product areas.
Rely on high quality research curated through systematic and comprehensive data collection methods.
Understand the nature and level of each company’s involvement.
Gain access to our dedicated team of product and topic experts.
Receive up-to-date information on companies’ business activities.
Controversial Product Involvement Report
Our product involvement reports identify the nature and extent of a company’s involvement in a range of product and business activities. Each activity is accompanied with a concise summary of the way the company is involved in the relevant product or activity.
Areas of Involvement
Oil and Gas
Genetically Modified Plants & Seeds
*Our Life Ethics research includes product involvement screening for abortion, contraceptives and human embryonic stem cell & fetal tissue.
*More comprehensive research available through the Controversial Weapons Radar service.
Fur & Specialty Leather
A Single Market Standard
Consistent approach to ESG assessments across the investment spectrum.
Award-Winning Research and Data
Firm recognized as Best ESG Research and Data Provider by Environmental Finance and Investment Week.
End-to-End ESG Solutions
ESG products and services that serve the entire investment value chain.
30 Years of ESG Expertise
800+ ESG research analysts across our global offices.
A Leading SPO Provider
As recognized by Environmental Finance and the Climate Bonds Initiative.
Create a robust defense policy with our Controversial Weapons Radar and Arms Trade Research.Learn More
Engage with companies that breach international norms and standards as identified by our Global Standards Screening research.Learn More
Pure exposure to exemplary ESG companies .
High Income generating equity investments focused on total returns with reduced ESG Risk.
Best-in-class equity index that features reduced ESG risk profile with low to moderate tracking error.
Developed and emerging market companies that align with one or more of the UN SDGs.
Companies that are committed to racial and ethnic diversity as demonstrated by relevant programs and policies related to diversity, community development etc.
Related Insights and Resources
Regulating 'Forever' Chemicals: Examining Company Readiness and Investor Risk
Chemical companies face growing pressure to phase out some of the most hazardous substances from their product portfolios. Learn how well companies manage related risks and what upcoming regulations could mean for them and their investors.
Inconsistent Definition of ‘Sustainable Investments’ Across EU Regulations Could Cause (Unintentional) Greenwashing
The absence of clear parameters to support the regulatory definition of sustainable investments has pushed market participants to make judgment calls leading to diverging investor approaches.
EU's Iterative Approach to Sustainable Finance Regulations Isn't Perfect, But It's a Good Start
The EU Action Plan for Sustainable Finance has kept the European investment market busy over the past year. In this blog post, we highlight the merits that we see in the EU regulatory package. While not perfect, the regulation is a good start.
Post-COP15 Outlook: Evolving Investor Responsibilities in Biodiversity
Awaiting COP15’s Global Biodiversity Framework negotiation outcomes, financial market participants could face new regulatory pressure sooner than expected to integrate biodiversity assessment into their investment, decision-making processes.